Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout
Nearly 40% of beneficiaries were nonadherent to ULTs during the 1-year follow-up period. Adherence trajectory groups have unique characteristics that could help to target interventions and improve patient care.
Authors
- Susan dosReis (ORCID: https://orcid.org/0000-0003-2210-6650)
- John G. Rizk (ORCID: https://orcid.org/0000-0002-5216-8695)
- Danya M. Qato (ORCID: https://orcid.org/0000-0002-6355-1526)
- Clifton Bingham
Institutions
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-07-24
- DOI
- https://doi.org/10.18553/jmcp.2025.31.8.795
- Citations
- 1
- Primary Topic
- Gout, Hyperuricemia, Uric Acid
- Type
- article
- Field-Weighted Citation Impact
- 1.43